4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-24-000056
President & COO sold 847 shares at $16.00 ($13,552)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dowden Nathan J President & COO | 2024-09-26 | Sale 10b5-1 | −847 | $16.00 | $13,552 | 125,149 | D: show line 1 in the form |
| Open-market sales · 847 sh · avg $16.00 · $13,552 | |||||||
Loading xslF345X05/wk-form4_1727728325.xml…